Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans.
Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans.
复制标题
DOI:
10.1038/mi.2008.77
复制
发表时间:
2009-03
影响因子:
8
通讯作者:
Wehkamp, J.
中科院分区:
文献类型:
--
作者:
Moendel, M.;Schroeder, B. O.;Zimmermann, K.;Huber, H.;Nuding, S.;Beisner, J.;Fellermann, K.;Stange, E. F.;Wehkamp, J.
Inducible epithelial human β-defensins (hBD) play an important role in intestinal barrier function. In vitro studies showed that clinically effective probiotics induce antimicrobial hBD-2. Here, we aimed to assess the in vivo effect in healthy volunteers and also addressed how defensins affect probiotic survival. Symbioflor 2 containing one strain of several viable genotypes of Escherichia coli was administered to 23 healthy individuals. After 3 weeks, fecal hBD-2 peptide was increased in 78% (mean 3.7-fold; P<0.0001). Interestingly, the fecal hBD-2 peptide was still elevated 9 weeks after treatment (P=0.008). In vitro studies revealed that this effect was mediated by only one out of three tested E. coli genotypes and comparable to probiotic E. coli Nissle 1917 (10- to 15-fold). Functional assays showed that all tested bacteria were similarly killed by defensins allowing to speculate about a suicidal character of this effect. Defensin induction seems to be a common and important mechanism of probiotic treatment.
登录
查看更多内容
影响因子:
4.5
作者:
Gionchetti, P;Amadini, C;Campieri, M
通讯作者:
Campieri, M
影响因子:
24.5
作者:
Kruis, W;Fric, P;Schulze, J
通讯作者:
Schulze, J
影响因子:
4.6
作者:
Schlee, M.;Harder, J.;Fellermann, K.
通讯作者:
Fellermann, K.
影响因子:
7.1
作者:
Marteau, PR;de Vrese, M;Schrezenmeir, J
通讯作者:
Schrezenmeir, J
影响因子:
7.6
作者:
Kruis, W;Schutz, E;Stolte, M
通讯作者:
Stolte, M